302 related articles for article (PubMed ID: 17852014)
1. A screening assessment of cognitive impairment in patients with ALS.
Gordon PH; Wang Y; Doorish C; Lewis M; Battista V; Mitsumoto H; Marder K
Amyotroph Lateral Scler; 2007 Dec; 8(6):362-5. PubMed ID: 17852014
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Distinctions between the dementia in amyotrophic lateral sclerosis with frontotemporal dementia and the dementia of Alzheimer's disease.
Heidler-Gary J; Hillis AE
Amyotroph Lateral Scler; 2007 Oct; 8(5):276-82. PubMed ID: 17917849
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and patterns of cognitive impairment in sporadic ALS.
Ringholz GM; Appel SH; Bradshaw M; Cooke NA; Mosnik DM; Schulz PE
Neurology; 2005 Aug; 65(4):586-90. PubMed ID: 16116120
[TBL] [Abstract][Full Text] [Related]
5. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).
Woolley SC; York MK; Moore DH; Strutt AM; Murphy J; Schulz PE; Katz JS
Amyotroph Lateral Scler; 2010 May; 11(3):303-11. PubMed ID: 20433413
[TBL] [Abstract][Full Text] [Related]
6. Frontal lobe-mediated behavioral changes in amyotrophic lateral sclerosis: are they independent of physical disabilities?
Terada T; Obi T; Yoshizumi M; Murai T; Miyajima H; Mizoguchi K
J Neurol Sci; 2011 Oct; 309(1-2):136-40. PubMed ID: 21782199
[TBL] [Abstract][Full Text] [Related]
7. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS.
Raaphorst J; Beeldman E; Schmand B; Berkhout J; Linssen WH; van den Berg LH; Pijnenburg YA; Grupstra HF; Weikamp JG; Schelhaas HJ; Papma JM; van Swieten JC; de Visser M; de Haan RJ
Neurology; 2012 Sep; 79(13):1377-83. PubMed ID: 22972650
[TBL] [Abstract][Full Text] [Related]
8. Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience.
Oskarsson B; Quan D; Rollins YD; Neville HE; Ringel SP; Arciniegas DB
Amyotroph Lateral Scler; 2010; 11(1-2):244-7. PubMed ID: 19530013
[TBL] [Abstract][Full Text] [Related]
9. Cognitive change in ALS: a prospective study.
Abrahams S; Leigh PN; Goldstein LH
Neurology; 2005 Apr; 64(7):1222-6. PubMed ID: 15824350
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
[TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits in amyotrophic lateral sclerosis evaluated by event-related potentials.
Ogawa T; Tanaka H; Hirata K
Clin Neurophysiol; 2009 Apr; 120(4):659-64. PubMed ID: 19342291
[TBL] [Abstract][Full Text] [Related]
12. Detecting neurobehavioral changes in amyotrophic lateral sclerosis.
Grossman AB; Woolley-Levine S; Bradley WG; Miller RG
Amyotroph Lateral Scler; 2007 Feb; 8(1):56-61. PubMed ID: 17364437
[TBL] [Abstract][Full Text] [Related]
13. A rapid screening battery to identify frontal dysfunction in patients with ALS.
Flaherty-Craig C; Eslinger P; Stephens B; Simmons Z
Neurology; 2006 Dec; 67(11):2070-2. PubMed ID: 17159125
[TBL] [Abstract][Full Text] [Related]
14. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
15. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance.
Gordon PH; Delgadillo D; Piquard A; Bruneteau G; Pradat PF; Salachas F; Payan C; Meininger V; Lacomblez L
Amyotroph Lateral Scler; 2011 Sep; 12(5):372-8. PubMed ID: 21585273
[TBL] [Abstract][Full Text] [Related]
16. An observational study of cognitive impairment in amyotrophic lateral sclerosis.
Rippon GA; Scarmeas N; Gordon PH; Murphy PL; Albert SM; Mitsumoto H; Marder K; Rowland LP; Stern Y
Arch Neurol; 2006 Mar; 63(3):345-52. PubMed ID: 16533961
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis.
Kilani M; Micallef J; Soubrouillard C; Rey-Lardiller D; Dematteï C; Dib M; Philippot P; Ceccaldi M; Pouget J; Blin O
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Mar; 5(1):46-54. PubMed ID: 15204024
[TBL] [Abstract][Full Text] [Related]
18. A prospective cohort study of neuropsychological test performance in ALS.
Gordon PH; Goetz RR; Rabkin JG; Dalton K; McElhiney M; Hays AP; Marder K; Stern Y; Mitsumoto H
Amyotroph Lateral Scler; 2010 May; 11(3):312-20. PubMed ID: 20225929
[TBL] [Abstract][Full Text] [Related]
19. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis.
Osborne RA; Sekhon R; Johnston W; Kalra S
J Neurol Sci; 2014 Jan; 336(1-2):191-6. PubMed ID: 24239183
[TBL] [Abstract][Full Text] [Related]
20. The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood.
Roozendaal B; Kim S; Wolf OT; Kim MS; Sung KK; Lee S
Psychoneuroendocrinology; 2012 Jan; 37(1):20-6. PubMed ID: 21616601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
